SARAH NORRIS: Open Payments
NPI 1841285483 · LORIS, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 33 payments from 16 companies in 2025. Trend: 2023 $1,122 · 2024 $1,606 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $217 |
| AstraZeneca Pharmaceuticals LP | 7 | $111 |
| COLOPLAST CORP | 1 | $102 |
| Dexcom, Inc. | 3 | $72 |
| Amgen Inc. | 4 | $61 |
| Abbott Laboratories | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $47 |
| PFIZER INC. | 2 | $37 |
| Averitas Pharma Inc. | 1 | $36 |
Products named: VOQUEZNA, Altis, Dexcom G6 Transmitter, FARXIGA, OTEZLA, FREESTYLE LIBRE 3, Ozempic, PREVNAR 20.
Industry payments across SC — which companies pay providers there.
